Mark Upsdell - Net Worth and Insider Trading
Mark Upsdell Net Worth
The estimated net worth of Mark Upsdell is at least $21,579 dollars as of 2024-09-30. Mark Upsdell is the Director of Rapid Dose Therapeutics Corp and owns about 143,857 shares of Rapid Dose Therapeutics Corp (XCNQ:DOSE) stock worth over $21,579. Details can be seen in Mark Upsdell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Upsdell has not made any transactions after 2022-01-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Upsdell
Mark Upsdell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Upsdell owns 1 companies in total, including Rapid Dose Therapeutics Corp (XCNQ:DOSE) .
Click here to see the complete history of Mark Upsdell’s form 4 insider trades.
Insider Ownership Summary of Mark Upsdell
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
XCNQ:DOSE | Rapid Dose Therapeutics Corp | 2022-01-27 | Director |
Mark Upsdell Latest Holdings Summary
Mark Upsdell currently owns a total of 1 stock. Mark Upsdell owns 143,857 shares of Rapid Dose Therapeutics Corp (XCNQ:DOSE) as of January 27, 2022, with a value of $21,579.
Latest Holdings of Mark Upsdell
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
XCNQ:DOSE | Rapid Dose Therapeutics Corp | 2022-01-27 | 143,857 | 0.15 | 21,579 |
Holding Weightings of Mark Upsdell
Mark Upsdell Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Upsdell has made a total of 1 transactions in Rapid Dose Therapeutics Corp (XCNQ:DOSE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Rapid Dose Therapeutics Corp is the acquisition of 1,000 shares on January 27, 2022, which cost Mark Upsdell around $290.
Insider Trading History of Mark Upsdell
- 1
Mark Upsdell Trading Performance
GuruFocus tracks the stock performance after each of Mark Upsdell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Upsdell is 17.86%. GuruFocus also compares Mark Upsdell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Upsdell within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Upsdell's insider trading performs compared to the benchmark.
Performance of Mark Upsdell
Mark Upsdell Ownership Network
Mark Upsdell Owned Company Details
What does Rapid Dose Therapeutics Corp do?
Who are the key executives at Rapid Dose Therapeutics Corp?
Mark Upsdell is the Director of Rapid Dose Therapeutics Corp.
Rapid Dose Therapeutics Corp (XCNQ:DOSE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Rapid Dose Therapeutics Corp (XCNQ:DOSE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rapid Dose Therapeutics Corp (XCNQ:DOSE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Rapid Dose Therapeutics Corp (XCNQ:DOSE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rapid Dose Therapeutics Corp Insider Transactions
Mark Upsdell Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Upsdell. Currently GuruFocus does not have mailing address information for Mark Upsdell.